BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31550443)

  • 1. Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.
    Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
    Arch Biochem Biophys; 2019 Nov; 676():108112. PubMed ID: 31550443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.
    Jia ZK; Wang JX; Yang JJ; Xue R; Zhang D; Wang GN; Ma SL; Duan ZF
    Chin Med J (Engl); 2012 May; 125(10):1727-32. PubMed ID: 22800891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors.
    Zhang J; Guo F; Wang L; Zhao W; Zhang D; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
    Int J Mol Sci; 2014 Sep; 15(9):16186-95. PubMed ID: 25222555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of post-traumatic stress-related serum factors in children with Wilms' tumors.
    Zhang J; Hu Q; Guo F; Wang L; Zhao W; Zhang DA; Yang H; Yu J; Niu L; Yang F; Zheng S; Wang J
    Oncol Lett; 2016 Feb; 11(2):1299-1304. PubMed ID: 26893734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
    Rebhandl W; Rami B; Turnbull J; Felberbauer FX; Paya K; Bancher-Todesca D; Gherardini R; Mittlboeck M; Horcher E
    Br J Cancer; 1998 Dec; 78(11):1503-6. PubMed ID: 9836484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
    Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
    Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.
    Wang J; Wang L; Zhang D; Fan Y; Jia Z; Qin P; Yu J; Zheng S; Yang F
    Mol Biol Rep; 2012 May; 39(5):5095-104. PubMed ID: 22160518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
    Zhang Q; Wang J; Dong R; Yang S; Zheng S
    Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
    Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
    Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
    Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of truncated midkine in Wilms' tumor by a monoclonal antibody against human recombinant truncated midkine.
    Paul S; Mitsumoto T; Asano Y; Kato S; Kato M; Shinozawa T
    Cancer Lett; 2001 Feb; 163(2):245-51. PubMed ID: 11165761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
    Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors.
    Zhao W; Li J; Zhang Y; Gao P; Zhang J; Guo F; Yu J; Zheng S; Wang J
    Oncol Lett; 2015 Jul; 10(1):233-239. PubMed ID: 26171005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Bcl-2 in Wilms' tumor and oncogenic potential of Bcl-X(L) in rare tumor cases.
    Re GG; Hazen-Martin DJ; El Bahtimi R; Brownlee NA; Willingham MC; Garvin AJ
    Int J Cancer; 1999 Apr; 84(2):192-200. PubMed ID: 10096254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples.
    Hammer E; Ernst FD; Thiele A; Karanam NK; Kujath C; Evert M; Völker U; Barthlen W
    Clin Chim Acta; 2014 Jun; 433():235-41. PubMed ID: 24680863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of biomarkers in children with Wilms' tumor using proteinchip technology.
    Zhang Q; Shan Y; Wang JX; Dong R; Yang SB; Zheng S
    Chin Med J (Engl); 2010 Jul; 123(14):1939-41. PubMed ID: 20819581
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening and identification of apolipoprotein A-I as a potential marker for hepatoblastoma in children].
    Guo LH; Zhao W; Zhang JJ; Zhang Q; Fan YZ; Wang JX
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1205-1210. PubMed ID: 27974108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.